Gujarat Terce Laboratories has informed that pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III to the said Regulations, the Board of Directors of the Company, at its Meeting held on Thursday, 13th February, 2020 which commenced at 3:00 pm and concluded at 4:00 pm have approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended on December 31, 2019; the Limited Review Report of the Statutory Auditors (USS & Associates) is with unmodified opinion with respect to the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended on December 31, 2019; the appointment of Ashka Solanki as the Company Secretary and Compliance Officer of the Company; re-constitution of Committees of the Company; the launch of New Territory of the Company at Patna, Bihar; and taken note of the fact and declared that Terce Wellness LLP ceases to be Associate LLP of Gujarat Terce Laboratories.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1515.00 |
Dr. Reddys Lab | 6080.25 |
Cipla | 1565.50 |
Zydus Lifesciences | 1110.95 |
Lupin | 1601.00 |
View more.. |